Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women’s health - Says subsidiary Inaphaea Biolabs Ltd enters agreement with OncoBone Ltd. Says OncoBone clients will be able to access Inaphaea services. Notes Inaphaea is now confirmed as a cell-based assay supplier to OncoBone. Adds Inaphaea’s services are now listed on scientist.com, a database website used by biotechnology and pharmaceutical companies.
Current stock price: 8.04 pence, down 0.7%
12-month change: down 59%
Copyright 2023 Alliance News Ltd. All Rights Reserved.